934 related articles for article (PubMed ID: 23841565)
1. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye.
Cömez AT; Tufan HA; Kocabıyık O; Gencer B
Curr Eye Res; 2013 Nov; 38(11):1095-103. PubMed ID: 23841565
[TBL] [Abstract][Full Text] [Related]
2. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
Benelli U; Nardi M; Posarelli C; Albert TG
Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
[TBL] [Abstract][Full Text] [Related]
3. Lubricant with gelling agent in treating dry eye in adult Chinese patients.
Waduthantri S; Yong SS; Tan CH; Htoon HM; Tong L
Optom Vis Sci; 2012 Nov; 89(11):1647-53. PubMed ID: 23069726
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops.
Ousler GW; Michaelson C; Christensen MT
Cornea; 2007 Sep; 26(8):949-52. PubMed ID: 17721294
[TBL] [Abstract][Full Text] [Related]
5. United States cost-effectiveness study of two dry eye ophthalmic lubricants.
Wlodarczyk J; Fairchild C
Ophthalmic Epidemiol; 2009; 16(1):22-30. PubMed ID: 19191178
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study.
Wang TJ; Wang IJ; Ho JD; Chou HC; Lin SY; Huang MC
Clin Ther; 2010 Jan; 32(1):44-52. PubMed ID: 20171410
[TBL] [Abstract][Full Text] [Related]
7. [Systane and cataract surgery].
Stefan C; Dumitrica DM
Oftalmologia; 2007; 51(4):100-4. PubMed ID: 18543684
[TBL] [Abstract][Full Text] [Related]
8. Intrasubject tear osmolarity changes with two different types of eyedrops.
Montani G
Optom Vis Sci; 2013 Apr; 90(4):372-7. PubMed ID: 23507972
[TBL] [Abstract][Full Text] [Related]
9. Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops.
Gensheimer WG; Kleinman DM; Gonzalez MO; Sobti D; Cooper ER; Smits G; Loxley A; Mitchnick M; Aquavella JV
J Ocul Pharmacol Ther; 2012 Oct; 28(5):473-8. PubMed ID: 22554205
[TBL] [Abstract][Full Text] [Related]
10. Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients.
Altiparmak UE; Acar DE; Ozer PA; Emec SD; Kasim R; Ustun H; Duman S
Eye (Lond); 2010 Jun; 24(6):1044-50. PubMed ID: 19834507
[TBL] [Abstract][Full Text] [Related]
11. Effect of artificial tears on tear stress test.
Khanal S; Simmons PA; Pearce EI; Day M; Tomlinson A
Optom Vis Sci; 2008 Aug; 85(8):732-9. PubMed ID: 18677237
[TBL] [Abstract][Full Text] [Related]
12. A comparative study to assess the clinical use of Fluorescein Meniscus Time (FMT) with Tear Break up Time (TBUT) and Schirmer's tests (ST) in the diagnosis of dry eyes.
Kallarackal GU; Ansari EA; Amos N; Martin JC; Lane C; Camilleri JP
Eye (Lond); 2002 Sep; 16(5):594-600. PubMed ID: 12194075
[TBL] [Abstract][Full Text] [Related]
13. Systane® ultra lubricant eye drops for treatment of contact lens-related dryness.
McDonald M; Schachet JL; Lievens CW; Kern JR
Eye Contact Lens; 2014 Mar; 40(2):106-10. PubMed ID: 24552755
[TBL] [Abstract][Full Text] [Related]
14. Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?
Essa L; Laughton D; Wolffsohn JS
Cont Lens Anterior Eye; 2018 Feb; 41(1):60-68. PubMed ID: 28811095
[TBL] [Abstract][Full Text] [Related]
15. [Taufon use in myopic contact lens wearers].
Naumenko VV; Pogosian MA; Sergeev VP
Vestn Oftalmol; 2014; 130(4):97-8, 100-1. PubMed ID: 25306731
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye.
Sall KN; Cohen SM; Christensen MT; Stein JM
Eye Contact Lens; 2006 Jan; 32(1):21-6. PubMed ID: 16415689
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management.
Sullivan BD; Crews LA; Sönmez B; de la Paz MF; Comert E; Charoenrook V; de Araujo AL; Pepose JS; Berg MS; Kosheleff VP; Lemp MA
Cornea; 2012 Sep; 31(9):1000-8. PubMed ID: 22475641
[TBL] [Abstract][Full Text] [Related]
18. Short-term consumption of oral omega-3 and dry eye syndrome.
Kangari H; Eftekhari MH; Sardari S; Hashemi H; Salamzadeh J; Ghassemi-Broumand M; Khabazkhoob M
Ophthalmology; 2013 Nov; 120(11):2191-6. PubMed ID: 23642375
[TBL] [Abstract][Full Text] [Related]
19. Tear osmolarity measurements in dry eye related to primary Sjögren's syndrome.
Utine CA; Bıçakçıgil M; Yavuz S; Çiftçi F
Curr Eye Res; 2011 Aug; 36(8):683-90. PubMed ID: 21780917
[TBL] [Abstract][Full Text] [Related]
20. Assessment of tear osmolarity and other dry eye parameters in post-LASIK eyes.
Hassan Z; Szalai E; Berta A; Modis L; Nemeth G
Cornea; 2013 Jul; 32(7):e142-5. PubMed ID: 23665645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
